Shares of Castle Biosciences slid 6.47% to $79.54 at 14:35 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is sliding 1.65% to $13,309.70, following last session’s downward trend, This seems, as yet, an all-around rough trend trading session today.

Castle Biosciences’s last close was $85.04, 35.39% under its 52-week high of $107.69.

The company’s growth estimates for the current quarter and the next is a negative 209.1% and a negative 466.7%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 3%, now sitting on 62.98M for the twelve trailing months.


Castle Biosciences’s last day, last week, and last month’s average volatility was 6.70%, 3.65%, and 4.88%, respectively.

Castle Biosciences’s last day, last week, and last month’s high and low average amplitude percentage was 10.22%, 7.96%, and 8.38%, respectively.

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $79.54 at 14:35 EST, way under its 52-week high of $107.69 and way above its 52-week low of $21.01.

Castle Biosciences’s Moving Average

Castle Biosciences’s worth is below its 50-day moving average of $80.65 and way higher than its 200-day moving average of $58.77.


Please enter your comment!
Please enter your name here